R-009-001 FR AbbVie Calculators 20250926
- Deal Id: 44587524449
- Deal name: FR AbbVie Calculators
Project Summary
Details
- Desired Start Date: 2026-Q2 (post contract signature)
- Duration: 12 months
- Scoring Systems: PASI (Psoriasis) and EASI (Atopic Dermatitis)
- Languages: fr
- Countries: France
- Deal value: EUR 110,000
Technical Implementation
- Product: Calculator (x2)
- AI Status: Existing AI models ready to use. No AI development required.
- UI Status: Requires custom UI/UX design and frontend development.
- Domain: TBD (e.g. pasi-abbvie.legit.health, easi-abbvie.legit.health)
UI/UX Requirements
- Mockup: TBD
- Copywriting / Content: TBD
- Logo & Naming: AbbVie brand assets required --- to be provided by client
Objectives
- Provide a ready-to-use, branded severity assessment calculator for Psoriasis (PASI).
- Provide a ready-to-use, branded severity assessment calculator for Atopic Dermatitis (EASI).
- Deliver exclusive calculators for AbbVie France (not shared with other clients).
- Ensure patient data is erased after download --- no data retention.
Scope
The scope includes UI/UX design, frontend development, API integration (with existing algorithms), quality assurance, and deployment of two custom calculators (PASI and EASI). It does not include the development or training of new AI models or data science efforts. Additionally, data handling must comply with the client's requirement for data erasure after download.
Success Metrics
- Successful deployment of both calculators.
- Tool adoption (e.g., number of assessments performed).
- Compliance with data erasure policy --- no patient data retained after download.
Doubts, questions and issues
These are certain issues that need to be solved or clarified in order to clearly define this project.
warning
Any doubt or comment clarified in this section must be accompanied by a modification in its respective section.
- What specific PASI calculator modifications does AbbVie require beyond branding (e.g., custom scoring logic, custom input fields, custom result display)?
- What specific EASI calculator modifications does AbbVie require?
- Exact definition of "exclusivity" --- geographic (France only), temporal (contract duration), or permanent?
- Exact definition of "erasing information after download" --- does this mean (a) no server-side storage after PDF/report is generated, (b) automatic session cleanup, or (c) something else?
- Which AbbVie brand guidelines and assets (logo, color palette, typography) need to be applied?
- Preferred domain naming convention for the two calculators.
- Are there specific regulatory or compliance requirements from AbbVie's legal team?
Project timeline and milestones
warning
The dates provided in the timeline are for reference purposes only; final dates will be determined following contract signature.
Project tasks
🧭 Definition & planning
| Task | Description | Responsible | Start Date | End Date | Status | Notes |
|---|---|---|---|---|---|---|
| Project conception and initiation | Initial ideation and opportunity scoping with all key stakeholders. | Deal Owner | 2025-09-26 | 2026-01-19 | ✅ Done | |
| Definition and planning | Define project details: scope, UI requirements, timelines. | Deal Owner & JD-013 | 2026-01-19 | 2026-03-15 | ✅ Done | 7 meetings held between Jan--Apr 2026 |
| Implementation plan defined | Project scope, key deliverables, timelines, success metrics, and required resources are defined and clear | Deal Owner & JD-013/JD-027 | 2026-03-15 | 2026-03-15 | ✅ Done | |
| Offer Sent | Formal offer/proposal shared with the customer for review. | Deal Owner & JD-002 | 2026-03-15 | 2026-03-17 | ✅ Done |
📝 Contracting
| Task | Description | Responsible | Start Date | End Date | Status | Notes |
|---|---|---|---|---|---|---|
| Offer Review | Customer internal review period. | AbbVie | 2026-03-17 | 2026-03-31 | ⏳ Pending | |
| Offer Approved | Customer reviews and approves the proposed scope, terms, and pricing. | AbbVie | 2026-03-31 | 2026-04-07 | ⏳ Pending | |
| Contract Review | Align on deliverables, timelines, legal and data terms. | Deal Owner & AbbVie | 2026-04-07 | 2026-04-21 | ⏳ Pending | |
| Contract Signing | Finalize and sign all contractual agreements. | AbbVie | 2026-04-21 | 2026-04-21 | ⏳ Pending |
🏁 Kickoff
| Task | Description | Responsible | Date | Status |
|---|---|---|---|---|
| Kick-off Meeting | Initial meeting to align on project goals, timelines, and responsibilities. | Deal Owner & JD-016/JD-029 | 2026-04-24 | ⏳ Pending |
🎨 UI/UX Design Phase
| Task | Description | Responsible | Start Date | End Date | Status |
|---|---|---|---|---|---|
| PASI Calculator UI Mockups | Create mockups of the PASI calculator landing page and assessment flow. | JD-008 | 2026-04-24 | 2026-05-04 | ⏳ Pending |
| EASI Calculator UI Mockups | Create mockups of the EASI calculator landing page and assessment flow. | JD-008 | 2026-04-24 | 2026-05-04 | ⏳ Pending |
| Internal Review & Approval | Review of mockups internally and with AbbVie, iterate on feedback. | Deal Owner | 2026-05-04 | 2026-05-11 | ⏳ Pending |
🛠️ Development & Setup
| Task | Description | Responsible | Start Date | End Date | Status |
|---|---|---|---|---|---|
| PASI Frontend Development | Implementation of the approved PASI calculator UI mockups. | JD-010/JD-007 | 2026-05-11 | 2026-05-25 | ⏳ Pending |
| EASI Frontend Development | Implementation of the approved EASI calculator UI mockups. | JD-010/JD-007 | 2026-05-11 | 2026-05-25 | ⏳ Pending |
| API Integration | Connect both calculator frontends to the existing AI algorithm endpoints. | JD-010/JD-007 | 2026-05-25 | 2026-06-01 | ⏳ Pending |
| Data Erasure Implementation | Implement automatic data erasure after download per AbbVie's privacy requirement | JD-010/JD-007 | 2026-06-01 | 2026-06-06 | ⏳ Pending |
| Internal QA | End-to-end testing of both calculators and cross-browser compatibility. | JD-013/JD-027 | 2026-06-06 | 2026-06-11 | ⏳ Pending |
🚀 Project Execution
| Task | Description | Responsible | Start Date | End Date | Status |
|---|---|---|---|---|---|
| Go Live & Launch | Publish both calculator landing pages and share the final URLs with AbbVie. | Deal Owner & JD-010 | 2026-06-11 | 2026-06-11 | ⏳ Pending |
| Customer Support | Setup and activate helpdesk or in-app support systems. Comprehensive assistance for complex issues | Deal Owner & JD-029/JD-016 | 2026-06-11 | 2027-06-11 | ⏳ Pending |
🔁 Follow-up Meetings
| Task | Description | Date | Responsible | Status |
|---|---|---|---|---|
| Follow-up 6 mo. | Formal review of key findings, feedback, and performance. | 2026-12-11 | Deal Owner & JD-029/JD-016 | ⏳ Pending |
✅ Project Close
| Task | Description | Start Date | End Date | Responsible | Status |
|---|---|---|---|---|---|
| Final Report | Analyze final outcomes, compare against objectives, and document results. | 2027-06-11 | 2027-06-18 | Deal Owner & JD-029/JD-016 | ⏳ Pending |
| Final Meeting | Formal review of the final report and project closure discussion. Also, define next steps if possible to continue collaboration. | 2027-06-18 | 2027-06-19 | Deal Owner & JD-029/JD-016 | ⏳ Pending |
Clinical Workflows
This section provides the implementation guidelines and clinical logic for the Calculator project.
System Architecture & Logic
Calculator Landing Page Flow
For healthcare professionals, the calculator is accessed via a dedicated landing page URL. They can securely upload patient images and answer any required clinical questions. The system processes the data using our existing AI models and returns the severity assessment score. All patient data is erased automatically after the report is downloaded.
Interaction Flow
Meeting history
| Date | Title |
|---|---|
| 2026-01-19 | Catch-up AbbVie X Legit.Health |
| 2026-01-30 | AbbVie X Legit.Health Proposal Update |
| 2026-02-04 | Catch-Up Legit.Health X AbbVie France |
| 2026-02-06 | Catch-Up AbbVie Legit.Health |
| 2026-02-24 | Legit.Health and AbbVie |
| 2026-04-09 | Legit.Health X AbbVie France |
| 2026-04-10 | AbbVie & Legit.Health |
Project leads
| Team | Code | Leader of |
|---|---|---|
| Us | JD-002, JD-008, JD-019 | Sales Manager, Business Development Manager, Sales Development Representative, Digital Health Manager |
| Us | JD-003, JD-013 | Design and Development Manager, Project Manager |
| Us | JD-018 | Clinical Research Manager |
| Us | JD-004 | Quality Manager & PRRC |
| Us | JD-007, JD-010 | Technology Manager, Software developer |
| Us | JD-005, JD-009 | Machine Learning Manager, Medical Data Scientist |
| Us | JD-014 | Data Analyst |
| Us | JD-016 | Customer Success Manager |
| Us | JD-021 | Account Manager |
| AbbVie | Aymeric Colleville | Business Excellence Manager, Innovation Hub Lead |
| AbbVie | Pierre-Alexandre Dupont | Business Unit Manager Dermatology |
| AbbVie | Marion Colin | Marketing Manager Dermatology |
| AbbVie | Louis Santos | Business Excellence & Advanced Customer Engagement Transformation Head |
Signature meaning
The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:
- Author: Team members involved
- Reviewer: JD-003 Design & Development Manager, JD-004 Quality Manager & PRRC
- Approver: JD-001 General Manager
ㅤㅤ ㅤ